This HTML5 document contains 109 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://dx.doi.org/10.1124/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34532913
rdf:type
wikibase:Item
schema:description
article scientific 2003年论文 2003年论文 ২০০৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ articolo scientifico article scientifique (publié 2003) artigo científico (publicado na 2003) научна статия مقالهٔ علمی tudományos cikk vedecký článok наукова стаття, опублікована в травні 2003 επιστημονικό άρθρο 2003 nî lūn-bûn artikull shkencor 2003 թվականի մայիսին հրատարակված գիտական հոդված 2003年の論文 artykuł naukowy vitskapeleg artikkel scientific article vetenskaplig artikel artículu científicu espublizáu en 2003 2003년 논문 artigo científico 2003年論文 wetenschappelijk artikel scienca artikolo 2003年论文 articol științific vitenskapelig artikkel teaduslik artikkel научни чланак מאמר מדעי 2003年論文 บทความทางวิทยาศาสตร์ 2003年论文 mokslinis straipsnis wissenschaftlicher Artikel مقالة علمية bài báo khoa học artículo científico publicado en 2003 2003年論文 2003年論文 სამეცნიერო სტატია vědecký článek 2003年论文 artigo científico (publicado na 2003) 2003 թուականի Մայիսին հրատարակուած գիտական յօդուած научная статья мақолаи илмӣ artikulong pang-agham videnskabelig artikel (udgivet 2003) naučni članak سائنسی مضمون 2003年論文 научни чланак tieteellinen artikkeli мақолаи илмӣ 2003年论文 article científic bilimsel makale
p:P577
wds:Q34532913-65ACE760-92B0-41B3-89ED-8C8615E1F88D
wdt:P577
2003-05-01T00:00:00Z
p:P407
wds:Q34532913-B1151DBF-4D57-4761-B6F7-CC423533B8F8
wdt:P407
wd:Q1860
p:P2093
wds:Q34532913-2F714C0B-908A-4237-AB8D-671AC96AC852 wds:Q34532913-7D673B93-3091-48A7-8E3D-080946073C22 wds:Q34532913-7DF9BAF6-4060-4934-9A70-49702162B83C wds:Q34532913-A0DEE076-6F87-4926-8A76-9462F2DECFDA wds:Q34532913-C2FC01D4-876E-4CDB-B9AF-A1217C45FD9A wds:Q34532913-C50F156A-7CDB-40CC-A114-EF1E37308977
wdt:P2093
Peter B Jensen Lars H Jensen Maxwell Sehested Axelle Renodon-Cornière Tina K Sørensen Birgitte Søkilde
rdfs:label
Probing the role of linker substituents in bisdioxopiperazine analogs for activity against wild-type and mutant human topoisomerase II alpha Probing the role of linker substituents in bisdioxopiperazine analogs for activity against wild-type and mutant human topoisomerase II alpha Probing the role of linker substituents in bisdioxopiperazine analogs for activity against wild-type and mutant human topoisomerase II alpha
skos:prefLabel
Probing the role of linker substituents in bisdioxopiperazine analogs for activity against wild-type and mutant human topoisomerase II alpha Probing the role of linker substituents in bisdioxopiperazine analogs for activity against wild-type and mutant human topoisomerase II alpha Probing the role of linker substituents in bisdioxopiperazine analogs for activity against wild-type and mutant human topoisomerase II alpha
schema:name
Probing the role of linker substituents in bisdioxopiperazine analogs for activity against wild-type and mutant human topoisomerase II alpha Probing the role of linker substituents in bisdioxopiperazine analogs for activity against wild-type and mutant human topoisomerase II alpha Probing the role of linker substituents in bisdioxopiperazine analogs for activity against wild-type and mutant human topoisomerase II alpha
p:P50
wds:Q34532913-9B287D2B-3AFA-4E9B-9C8D-F072C9385C9A
wdt:P50
wd:Q42114775
p:P1476
wds:Q34532913-72E429C0-6DB0-44ED-A5FC-17F9FDC2C8C8
wdt:P1476
Probing the role of linker substituents in bisdioxopiperazine analogs for activity against wild-type and mutant human topoisomerase II alpha
p:P304
wds:Q34532913-1C5DFC39-37A1-4F73-B03D-4B06B91C22C8
wdt:P304
1159-1168
p:P31
wds:Q34532913-18427A5A-1F21-4B5C-9F94-47DE328A250B
wdt:P31
wd:Q13442814
p:P698
wds:Q34532913-79B4C230-5F51-4747-AF7D-108A70BC4FB5
wdtn:P698
n11:12695544
wdt:P698
12695544
p:P1433
wds:Q34532913-6F7F6F2D-18F7-4A1D-AE62-CB8A83080E43
wdt:P1433
wd:Q1943386
p:P433
wds:Q34532913-8FD1CF2D-799F-4979-B417-F83ECE13ECCE
p:P478
wds:Q34532913-83052A5B-D8AE-4F72-AB0F-522E5275C817
wdt:P433
5
wdt:P478
63
p:P356
wds:Q34532913-E7E06F2A-F43D-4983-B7DB-C0143A35A44B
wdtn:P356
n5:MOL.63.5.1159
wdt:P356
10.1124/MOL.63.5.1159
p:P5875
wds:Q34532913-AE1C7554-F812-41FD-9CCC-24D64A479477
wdt:P5875
240272069